Dr. Joseph A. Califano III, MD

Dr. Califano practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Califano's NPI, 1881652972, was assigned on May 1, 2006. Dr. Califano graduated from Harvard Medical School in 1993. Dr. Califano holds California license G138926.

Dr. Califano's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Califano's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Califano is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Califano practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Califano's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Califano is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Califano's licenses on file in 3 states: California, Maryland and New York.

Dmand AI lists endoscopic sinus surgery and thyroid surgery among the conditions Dr. Califano treats.

CMS data shows 233 Medicare services from Dr. Califano across 4 procedure codes in 2024, for 134 Medicare patients. Medicare paid $14,210 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 134 Medicare patients who saw Dr. Califano in 2024. The largest group is 65 to 74, with 61 patients. 68% of them have high blood pressure, and 67% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Califano's median patient age at 65, with 43% women.

In 2024, Dr. Califano wrote 46 Medicare Part D claims for 29 patients. 100% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $40,032 in total drug cost. In 2021, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Califano for performance year 2024, reported as part of a group. Dr. Califano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Califano as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 320 papers to Dr. Califano, published from 2004 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and DNA Methylation. Dr. Califano has published most often in Clin Cancer Res. Dr. Califano's most frequent co-authors are Patrick Ha, MD, Theresa Wen Wen Guo, MD and Carole Fakhry, MD.

Dmand AI links Dr. Califano to 1 clinical trial. Conditions studied include Hypopharyngeal Neoplasms and Laryngeal Neoplasms.

CMS Open Payments shows 16 general payments to Dr. Califano from 6 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 79% of the total. Intuitive Surgical, Inc. paid the most, $1,043.

Dmand AI lists 9 awards for Dr. Califano, most recently CMS Stage 1 EHR in 2013.

Dr. Califano graduated from Harvard Medical School in 1993. Dr. Califano is a member of NHS.

Dr. Califano is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.